Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
The American Journal of Gastroenterology
|
September 11, 1998
Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease
C Cellier, J P Cervoni, N Patey, et al.
The American Journal of Gastroenterology
|
September 28, 2011
Long-term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions
E Samaha, G Rahmi, B Landi, et al.
British Journal of Cancer
|
April 20, 2006
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients
M Mabro, P Artru, T André, et al.
Annales Pharmaceutiques Francaises
|
October 14, 1998
[Evaluation and interest in new molecular markers in colon cancer]
V Le Maire, J P Sales, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
J Taïeb, T Lecomte, T Aparicio, et al.
Gastrointestinal Endoscopy
|
October 28, 1999
Push enteroscopy in celiac sprue and refractory sprue
C Cellier, E Cuillerier, N Patey-Mariaud de Serre, et al.
Gastroenterology
|
May 1, 1992
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives
B Landi, T N Anh, A Cortot, et al.
Surgery
|
May 2, 2001
Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients
R Douard, V Le Maire, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
C Louvet, T André, P Hammel, et al.
Critical Reviews in Oncology/Hematology
|
April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
M Bouchahda, T Macarulla, J P Spano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
The American Journal of Gastroenterology
|
September 11, 1998
Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease
C Cellier, J P Cervoni, N Patey, et al.
The American Journal of Gastroenterology
|
September 28, 2011
Long-term outcome of patients treated with double balloon enteroscopy for small bowel vascular lesions
E Samaha, G Rahmi, B Landi, et al.
British Journal of Cancer
|
April 20, 2006
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients
M Mabro, P Artru, T André, et al.
Annales Pharmaceutiques Francaises
|
October 14, 1998
[Evaluation and interest in new molecular markers in colon cancer]
V Le Maire, J P Sales, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
J Taïeb, T Lecomte, T Aparicio, et al.
Gastrointestinal Endoscopy
|
October 28, 1999
Push enteroscopy in celiac sprue and refractory sprue
C Cellier, E Cuillerier, N Patey-Mariaud de Serre, et al.
Gastroenterology
|
May 1, 1992
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives
B Landi, T N Anh, A Cortot, et al.
Surgery
|
May 2, 2001
Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients
R Douard, V Le Maire, P Wind, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
C Louvet, T André, P Hammel, et al.
Critical Reviews in Oncology/Hematology
|
April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer
M Bouchahda, T Macarulla, J P Spano, et al.
Page
of 6